dr. leonard gomella examines the understating of provenge benefits
Published 12 years ago • 661 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:42
dr. leonard gomella on the provenge impact trial survival benefit
-
2:03
dr. gomella discusses the cost of the immunotherapy sipuleucel-t
-
2:28
dr. gomella discusses new data on sipuleucel-t
-
1:06
dr. leonard gomella on helping patients make informed medical decisions
-
1:08
dr. leonard gomella discusses the challenges of psa screening
-
1:22
dr. leonard gomella on the unique attributes of neoadjuvant zytiga
-
1:11
dr. leonard gomella discusses psa velocity
-
1:01
dr. leonard gomella on sequencing prostate cancer therapies
-
1:11
dr. gomella discusses precision medicine in prostate cancer
-
1:45
dr. gomella on current perspectives on prostate cancer screening
-
0:47
dr. alter discusses the immunotherapy provenge
-
0:45
dr. leonard gomella discusses aua's new prostate cancer guidelines
-
1:48
dr. gomella discusses the neoact sipuleucel-t study
-
1:00
dr. leonard gomella on the impact of the new uspstf psa rating
-
2:33
dr. leonard gomella on neoadjuvant hormonal therapy combined with abiraterone acetate
-
1:16
dr. alter discusses the provenge treatment process
-
1:09
dr. gomella on the challenges of genetic testing in prostate cancer
-
1:32
dr. gomella on screening in prostate cancer
-
1:37
dr. gomella on the state of genetic testing and screening in prostate cancer